- Home
- DATS vs PRPH Comparison
DATS vs PRPH Comparison
Compare DATS & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DATS
- PRPH
- Stock Information
- Founded
- DATS 2014
- PRPH 1989
- Country
- DATS United States
- PRPH United States
- Employees
- DATS N/A
- PRPH N/A
- Industry
- DATS Computer Software: Prepackaged Software
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- DATS Technology
- PRPH Health Care
- Exchange
- DATS Nasdaq
- PRPH Nasdaq
- Market Cap
- DATS 9.5M
- PRPH 10.7M
- IPO Year
- DATS 2021
- PRPH 1997
- Fundamental
- Price
- DATS $3.24
- PRPH $0.39
- Analyst Decision
- DATS
- PRPH
- Analyst Count
- DATS 0
- PRPH 0
- Target Price
- DATS N/A
- PRPH N/A
- AVG Volume (30 Days)
- DATS 8.0M
- PRPH 1.7M
- Earning Date
- DATS 05-13-2025
- PRPH 03-31-2025
- Dividend Yield
- DATS N/A
- PRPH N/A
- EPS Growth
- DATS N/A
- PRPH N/A
- EPS
- DATS N/A
- PRPH N/A
- Revenue
- DATS $436.00
- PRPH $6,770,000.00
- Revenue This Year
- DATS N/A
- PRPH N/A
- Revenue Next Year
- DATS N/A
- PRPH $64.06
- P/E Ratio
- DATS N/A
- PRPH N/A
- Revenue Growth
- DATS N/A
- PRPH N/A
- 52 Week Low
- DATS $1.01
- PRPH $0.22
- 52 Week High
- DATS $9.34
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- DATS 55.48
- PRPH 45.88
- Support Level
- DATS $3.09
- PRPH $0.35
- Resistance Level
- DATS $3.93
- PRPH $0.60
- Average True Range (ATR)
- DATS 0.60
- PRPH 0.08
- MACD
- DATS 0.12
- PRPH 0.00
- Stochastic Oscillator
- DATS 31.55
- PRPH 27.59
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts, even after they are sent.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.